Quality of life as measured by the short-form 36 (SF-36) questionnaire in patients with early systemic sclerosis and undifferentiated connective tissue disease

Health and Quality of Life Outcomes

Volumn 11, Issue 1, 2013, Pages

  Iudici, Michele ^a   Cuomo, Giovanna ^a   Vettori, Serena ^a   Avellino, Manuela ^a   Valentini, Gabriele ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Quality of life; Systemic sclerosis; Undifferentiated connective tissue disease

Indexed keywords

CARBON DIOXIDE;

ADOLESCENT; ADULT; ARTHRITIS; ARTICLE; CAPILLAROSCOPY; CLINICAL ARTICLE; CLINICAL EVALUATION; CONNECTIVE TISSUE DISEASE; ECHOCARDIOGRAPHY; FEMALE; GENERAL HEALTH QUESTIONNAIRE; HUMAN; LUNG DIFFUSION; LUNG FUNCTION; MALE; MENTAL HEALTH; PATIENT CARE; PERCEPTION; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 36; SYSTEMIC SCLEROSIS;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CONNECTIVE TISSUE DISEASES; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SCLERODERMA, SYSTEMIC; SELF-ASSESSMENT; YOUNG ADULT;

EID: 84874123656     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-11-23     Document Type: Article

References (24)

1. Wigley FM. Scleroderma (systemic sclerosis). Goldman: cecil medicine 2008, 2032-2041. Philadelphia, Pa: Saunders, Goldman L, Ausiello D, 23.
2. Al-Dhaher FF, Pope JE, Ouimet JM. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum 2010, 39:269-277. 10.1016/j.semarthrit.2008.06.002, 18706680.
3. Khanna D, Ahmed M, Furst DE, Ginsburg SS, Park GS, Hornung R, Tsevat J. Health values of patients with systemic sclerosis. Arthritis Rheum 2007, 57:86-93. 10.1002/art.22465, 17266070.
4. Steen VD, Medsger TA. The value of the health assessment questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997, 40:1984-1991. 10.1002/art.1780401110, 9365087.
5. Valentini G, Matucci Cerinic M. Disease-specific quality indicators, guidelines and outcome measures in scleroderma. Clin Exp Rheum 2007, 25(Suppl 47):159-162.
6. Thombs BD, Taillefer SS, Hudson M, Baron M. Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis Rheum 2007, 57:1089-1097. 10.1002/art.22910, 17665491.
7. Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M. Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions. J Rheumatol 2009, 36:768-772. 10.3899/jrheum.080281, 19228662.
8. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23:581-590. 10.1002/art.1780230510, 7378088, Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.
9. LeRoy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001, 28:1573-1576.
10. Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, Goulet JR, Rich E, Grodzicky T, Raymond Y, Senécal JL. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008, 58:3902-3912. 10.1002/art.24038, 19035499.
11. Doria A, Mosca M, Gambari PF, Bombardieri S. Defining unclassifiable connective tissue diseases: incomplete, undifferentiated or both?. J Rheumatol 2005, 32:3-5.
12. Valentini G, Cuomo G, Abignano G, Petrillo A, Vettori S, Capasso A, Cozzolino D, Del Genio G, Santoriello C. Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features. Rheumatology (Oxford) 2011, 50:317-323.
13. Sebastiani M, Manfredi A, Vukatana G, Moscatelli S, Riato L, Bocci M, Iudici M, Principato A, Mazzuca S, Del Medico P, De Angelis R, D'Amico R, Vicini R, Colaci M, Ferri C. Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study. Ann Rheum Dis 2012, 71:67-70. 10.1136/annrheumdis-2011-200022, 21917823.
14. Maricq HR. Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 1981, 24:1159-1165. 10.1002/art.1780240907, 7306237.
15. Scussel-Lonzetti L, Joyal F, Raynauld J-P, Roussin A, Rich E, Goulet J-R, et al. Predicting mortality in systemic sclerosis. Analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 2002, 81:154-167.
16. Maione S, Cuomo G, Giunta A, Tanturri de Horatio L, La Montagna G, Manguso F, Alagia I, Valentini G. Echocardiographic alterations in systemic sclerosis. A longitudinal study. Semin Arthritis Rheum 2005, 34:721-727. 10.1016/j.semarthrit.2004.11.001, 15846587.
17. Paone C, Chiarolanza I, Cuomo G, Ruocco L, Vettori S, Menegozzo M, La Montagna G, Valentini G. Twelve-month azathioprine as maintenance therapy in early diffuse systemic sclerosis patients treated for 1-year with low dose cyclophosphamide pulse therapy. Clin Exp Rheumatol 2007, 25:613-616.
18. Apolone G, Mosconi P. The Italian SF-36 health survey: translation, validation and norming. J Clin Epidemiol. 1998, 51:1025-1036. 10.1016/S0895-4356(98)00094-8, 9817120.
19. La Montagna G, Cuomo G, Chiarolanza I, Ruocco L, Valentini G. HAQ-DI Italian version in systemic sclerosis. Reumatismo 2006, 58:112-115.
20. De Angelis R, Salaffi F, Grassi W. Health-related quality of life in primary Raynaud phenomenon. J Clin Rheumatol 2008, 14:206-210. 10.1097/RHU.0b013e31817a2485, 18766120.
21. Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M. Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum. 2009, 61:1112-1120. 10.1002/art.24676, 19644906.
22. Arat S, Verschueren P, De Langhe E, Smith V, Vanthuyne M, Diya L, Van de Heede K, Blockmans D, De Keyser F, Houssiau FA, Westhovens R. The association of illness perceptions with physical and mental health in systemic sclerosis patients: an exploratory study. Musculoskeletal Care 2012, 10:18-28. 10.1002/msc.223, 22076953.
23. Ingegnoli F, Boracchi P, Gualtierotti R, Biganzoli EM, Zeni S, Lubatti C, Fantini F. Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: roleof autoantibodies and nail-fold capillaroscopy. Rheumatology (Oxford) 2010, 49:797-805.
24. Kallenberg CG, Wouda AA, Hoet MH, van Venrooij WJ. Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 1988, 47:634-641. 10.1136/ard.47.8.634, 1006713, 3261966.